Aspen Neuroscience

Biotech & Life Sciences · San Diego, United States · Founded 2018

Biotechnology company that uses innovative genomic approaches combined with stem cell biology MoreLess

Aspen Neuroscience, Inc., headquartered in San Diego, is a private biotechnology company specializing in personalized cell therapies for Parkinson's disease. The company leverages advanced stem cell biology and genomics to develop patient-specific treatments aimed at reversing the effects of the disease. Aspen Neuroscience operates in the healthcare and biotechnology market, primarily serving patients diagnosed with Parkinson's disease. The company's business model revolves around developing and commercializing its proprietary induced pluripotent stem cell (iPSC) platform, which combines cutting-edge artificial intelligence and genomic technologies. Revenue is generated through partnerships, licensing agreements, and potentially future sales of its cell therapy products. The company is in the development stage, focusing on research and clinical trials to bring its innovative therapies to market.

Keywords: personalized cell therapy, Parkinson's disease, stem cell biology, genomics, iPSC platform, biotechnology, healthcare, artificial intelligence, patient-specific treatments, clinical trials.

Valuation $500M–1B

Headcount 100–500

Total funding $100–500M

Unlock exact values

Company overview

Aspen Neuroscience company information

The essential company record, classifications and operating signals in one place.

Status: Operational
Founded: 2018
Headquarters: San Diego, United States
Employees: 127
Open positions: 13
Dealroom signal: 76.0

Website ↗LinkedIn ↗X ↗

client focusb2bsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorNeurologysectorDegenerative DiseasessectorChronic DiseasesectorRegenerative MedicinesectorPrecision MedicinesectorSpinoutsectorBiotech and PharmasectorCell TherapysectorWoman Founder

Valuation & funding

Aspen Neuroscience funding history

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Nov 2025	$115M	$738M	Kite Pharma · Section 32 · Lifeforce Capital · Medical Excellence Capital	—
GRANTOther financing	May 2024	$8M	—	California Institute for Regenerative Medicine	↗
DEBTDebt	Dec 2022	$40M	—	Silicon Valley Bank	↗
SERIES BOther financing	May 2022	$148M	$590M	ARCH Venture Partners · OrbiMed · Timefolio Capital · Medical Excellence Capital	↗
SERIES AOther financing	Apr 2020	$70M	$280M	Frazier Healthcare Partners · OrbiMed · ARCH Venture Partners · Section 32	↗
SEEDOther financing	Dec 2019			Alexandria Venture Investments · Domain Associates · ARCH Venture Partners · OrbiMed	—
SPINOUTOther financing	Nov 2018			Scripps Translational Science Institute	—

Showing 7 recorded eventsUnlock the complete deal history →

Growth signals

Aspen Neuroscience website traffic

Latest recorded traffic for Aspen Neuroscience is 4.4K monthly website visits, down 26.7% over the last three months. Aspen Neuroscience's team grew 3.3% over the past year.

Latest monthly visits4.4K 3-month web change-26.7% 1-year team growth+3.3%

Monthly website visits91 observations · Dec 2018–Jul 2026

Hover or focus a point to see its exact monthly valueCompare with peers →

Hiring

Open positions at Aspen Neuroscience

Current openings linked to this company in Dealroom.

Manufacturing Associate I (Day & Second Shift)San Diego, California, United States, Northern America, Americas · Other · Aug 27, 2026 Associate Director, Regulatory Affairs - CMCSan Diego, California, United States, Northern America, Americas · Full-Stack Development · Aug 27, 2026 Sr. Automation EngineerSan Diego, California, United States, Northern America, Americas · Other · Aug 27, 2026 Senior Automation EngineerSan Diego, CA · Other · Aug 26, 2026 Scientist I, MicrogliaSan Diego, CA · Other · Aug 25, 2026 Sr. Clinical Specialist, Surgical Operations (Northeast)New York, New York, United States, Northern America, Americas · Other · Jul 2, 2026 Sr. Clinical Specialist, Surgical Operations (Southeast/Texas)Tampa, Florida, United States, Northern America, Americas · Other · Jul 2, 2026 Scientist II, Bioinformatics QCSan Diego, CA · Other · Jul 2, 2026

8 distinct openings shownExplore hiring signals →

Comparisons

Aspen Neuroscience compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ETEikonizo TherapeuticsDeveloping therapies to improve the treatment of human disease, specifically neurodegenerative diseases	Cambridge, United States	Operational	13	$43M	$160M
CRCell Biopeutics ResourcesCommercializing mesenchymal stem cell therapeutics and cosmetics	Kuala Lumpur, Malaysia	Operational
EXexomasNeural stem cell exosomes for neurodegenerative diseases	Rosario, Argentina	Operational
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
MTMuna TherapeuticsDiscovering and developing transformative therapeutics for neurodegenerative diseases	Copenhagen, Denmark	Operational
OHOrbit HealthHarnessing sensors and AI, enables effective early intervention and personalized care for chronic diseases	Berlin, Germany	Operational
KAKadimastemA clinical stage biotech company using A cutting-edge TECHNOLOGY PLATFORM for the Development, Manufacturing, & Bio-Banking of human functional cells	Sapir, Israel	Operational
CICilcareAdvanced solutions for drug in hearing and ear disorders	Montpellier, France	Operational

Showing 8 of the closest matchesCompare every metric →

Talent graph

Aspen Neuroscience's talent

Book a demo to see the people

Team profiled 13 named & role-tagged

Founders /100 quality score

Key operators 5 quality /100

Potential founders likely future founders

Startup mafia alumni-founded startups

Talent movements in · out past 12 months

Source: Dealroom Talent Intelligence.

Investors

25 investors on Aspen Neuroscience's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 7 investors entered at this stage

Domain Associates

Alexandria Venture Investments

ARCH Venture Partners

OrbiMed

Section 32

Axon Ventures

California Institute for Regenerative Medicine

Series A 11 investors entered at this stage

Frazier Healthcare Partners

LYFE Capital

Revelation Partners

Timefolio Capital

Medical Excellence Capital

EDBI

Mirae Asset Capital

Sam Altman

Newton Investment Management

Lifeforce Capital

Series B+ 6 investors entered at this stage

Silicon Valley Bank

Frazier Life Sciences

Kite Pharma

The Conrad Prebys Foundation

Cormorant Asset Management

Balyasny Asset Management

Other known 1 additional known investor

Scripps Translational Science Institute

Global footprint

Where Aspen Neuroscience has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

In the news

Latest news about Aspen Neuroscience

Recent press, funding announcements, and product moves mentioning Aspen Neuroscience — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Aspen Neuroscience

An AI-synthesized read of the highest-engagement posts about Aspen Neuroscience on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aspen Neuroscience’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.